Are you looking to join a company where your contributions truly matter, and where you'll be part of a supportive, innovative team? MMS is a award-winning, data-focused clinical research organization (CRO). We pride ourselves on being a Gre...
experience (any industry, not necessarily pharma) · PECS talent will develop critical skills in areas including: o Shaping..., well-intended failures, and ex-pharma examples of creating value through experience; help to identify necessary changes in the...
Mechanic Improving Health through Science and Technology! At Aptar Pharma, we specialize in Drug Delivery offering... Innovative Devices, Services and Solutions focused on the Patient Experience. Aptar Pharma is part of Aptar Group, a global...
Industry Sales Developer – Life Sciences, BioPharma, Pharma Job Location: Any of the following locations: New England..., Pharma domain to ensure effective sales strategies are in place to achieve revenue and profitability objectives for the...
Are you looking to join a company where your contributions truly matter, and where you'll be part of a supportive, innovative team? MMS is a award-winning, data-focused clinical research organization (CRO). We pride ourselves on being a Gre...
Top Gainers and Losers Today : The Sensex gained 131.18 points, or 0.17, to settle at 77209.9, while the Nifty gained 36.75 points, or 0.16, to close at 23501.1. Continue Reading »
The negative reaction of the Ujjivan stock has widened its valuation gap with Equitas SFB, its closest peer in terms of both the balance sheet size and market capitalization. Continue Reading »
Stock market today: Nifty 50 closed with a mild gain of 37 points, or 0.16 per cent, at 23,537.85, while the Sensex ended 131 points, or 0.17 per cent, higher at 77,341.08. Continue Reading »
PSU stocks have surged sharply, driven by increased capex and government initiatives. BJP's election win further boosted the rally. Defence, power, and railways sectors are standout performers. Analysts are optimistic about the future growth prospects despite the significant rally in these stocks. Continue Reading »
Stanley Lifestyles IPO includes funding of ₹161.10 crore, subscription status of 4.18 times on the second day, and plans to open new stores and invest in equipment. Continue Reading »
Goldman Sachs highlights TBO's strong FCF generation and clean balance sheet. The brokerage forecasts an average annual margin expansion of 170 bps until FY30. It sees TBO as a steady earnings compounder and forecasts a 30% to 33% CAGR in EBITDA and net income from FY24 to FY30. Continue Reading »
Sylvan Plyboard IPO price has been set at ₹55 per share. The fixed price issue worth ₹28.05 crore is entirely a fresh issue of 51 lakh equity shares. Continue Reading »